Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
AEON Biopharma ( (AEON) ) just unveiled an update.
At a recent Special Meeting, AEON Biopharma’s stockholders approved several key proposals. These included an amendment to increase the number of authorized shares of Common Stock, granting the board discretionary authority for a reverse stock split, authorizing the issuance of warrants and shares in compliance with NYSE American listing rules, and approving potential adjournments to solicit additional proxies if needed. These decisions are poised to impact the company’s capital structure and market operations significantly.
More about AEON Biopharma
YTD Price Performance: -78.14%
Average Trading Volume: 18,494,218
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $9.62M
Find detailed analytics on AEON stock on TipRanks’ Stock Analysis page.